FDA outside experts face stricter rules on industry ties

08/4/2008 | Hill, The

The FDA announced that it will not let outside experts serve on an advisory panel if they or their immediate relatives have a financial stake of $50,000 or more in a drug or medical-device firm being reviewed. The restriction is part of the agency's new policies that address concerns about its independent advisers' industry relationships, including objectivity and conflicts of interest.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA